Parkinson's Clinical Trial Companion Accelerating Clinical Trials | Page 8

CA SE STUDY NO. 1 Engaging Key Stakeholders by Forming a Study Working Group The Clinician Input Study (CIS-PD) is a trial sponsored by The Michael J. Fox Foundation (MJFF) that seeks to assess the impact of wearable and mobile app data on clinical decision making for individuals with Parkinson’s disease (PD). Participants logged information on symptoms and medications via smartphone application; smartwatches collected movement data. Over the course of the study, an online dashboard allowed participants’ treating clinicians to assess the utility of the patient-reported and movement data on clinical care management. Computational scientists used the data to identify movement signatures of PD, (i.e., movements specific to PD) that are recognizable when an individual is wearing a smartwatch. Representative(s) + + Patient Representatives + + Community Engagement Representatives – MJFF + + Principal Investigator + + Project Managers – MJFF Several factors contributed to the decision to form a study working group, including the novelty of data collection methods, the in-home study design and the impact on a variety of stakeholders. The group’s goals were to identify and address potential study off-ramps as well as study design successes. To accomplish this, the working group included individuals participating in, implementing, or affected by the outcomes of the CIS-PD study. The table below lists the key stakeholder representatives, their perspectives and the areas of study design that their perspectives informed: Key Areas for Consideration Perspective + + Those who would be participating in the study + + Participant study burden + + Those who would be implementing the study + + Trial team burden + + The Technology Platform Provider + + Study logistics + + Technology capabilities and Imitations + + Data collection methods + + Computational Scientists + + Clinical endpoints + + The Data Management Unit + + Clinical Coordinators + + Patient Representatives + + Computational Scientists + + Those who would be affected by study outcomes + + Value to and utility for clinical care management + + Clinical Coordinators The working group reviewed all study documents including the research protocol, informed consent documents, case report forms and procedure manuals. This review process revealed that a series of the assessments proposed by the computational 6 Accelerating Clinical Trials: Best Practices for Recruitment and Retention scientists was both lengthy and potentially burdensome for patients and coordinators. Based on the working group feedback, the protocol was refined to ensure that there was balance between data collection and feasibility.